Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

Area of Science:

• Pulmonology
• Respiratory Medicine
• Clinical Research

Background:

• Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous respiratory condition.
• Current diagnostic and staging methods, like forced expiratory volume in one second, are limited in sensitivity and specificity.
• A deeper understanding of COPD subtypes and progression markers is crucial for effective management.

Purpose of the Study:

• To define clinically relevant subtypes of chronic obstructive pulmonary disease (COPD).
• To identify parameters and biomarkers that predict disease progression within these subtypes.
• To discover novel genetic factors and biomarkers associated with COPD subtypes and progression.

Main Methods:

• The Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) is a 3-year longitudinal study.
• Recruitment of 2,180 COPD subjects (GOLD categories II-IV) and control groups.
• Comprehensive assessments including pulmonary function tests, CT scans, biomarker analysis, and health outcomes.

Main Results:

• The study is the largest of its kind to investigate COPD heterogeneity.
• It aims to establish predictive markers for disease progression.
• Findings will contribute to a more nuanced understanding of COPD.

Conclusions:

• The ECLIPSE study is pivotal for characterizing COPD subtypes.
• It will identify key predictors of disease progression, advancing personalized medicine.
• Results are expected to refine diagnostic and therapeutic strategies for COPD.